{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:34:46Z","timestamp":1777581286768,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1038\/sj.mp.4001220","type":"journal-article","created":{"date-parts":[[2003,3,27]],"date-time":"2003-03-27T11:33:22Z","timestamp":1048764802000},"page":"343-347","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":189,"title":["Phospho-tau\/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt\u2013Jakob disease from other dementias"],"prefix":"10.1038","volume":"8","author":[{"given":"M","family":"Riemenschneider","sequence":"first","affiliation":[]},{"given":"S","family":"Wagenpfeil","sequence":"additional","affiliation":[]},{"given":"H","family":"Vanderstichele","sequence":"additional","affiliation":[]},{"given":"M","family":"Otto","sequence":"additional","affiliation":[]},{"given":"J","family":"Wiltfang","sequence":"additional","affiliation":[]},{"given":"H","family":"Kretzschmar","sequence":"additional","affiliation":[]},{"given":"E","family":"Vanmechelen","sequence":"additional","affiliation":[]},{"given":"H","family":"F\u00f6rstl","sequence":"additional","affiliation":[]},{"given":"A","family":"Kurz","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2003,3,27]]},"reference":[{"key":"BF4001220_CR1","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1056\/NEJM199609263351303","volume":"335","author":"G Hsich","year":"1996","unstructured":"Hsich G, Kenney K, Gibbs C, Lee KH, Harrington MG . The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 1996; 335: 924\u2013930.","journal-title":"N Engl J Med"},{"key":"BF4001220_CR2","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1212\/WNL.55.6.811","volume":"55","author":"I Zerr","year":"2000","unstructured":"Zerr I, Pocchiari M, Collins S, Brandel JP, de Pedro Cuesta J, Knight RSG et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000; 55: 811\u2013815.","journal-title":"Neurology"},{"key":"BF4001220_CR3","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1212\/WNL.56.11.1528","volume":"56","author":"P Burkhard","year":"2001","unstructured":"Burkhard P, Sanchez J-C, Landis T, Hochstrasser DF . CSF detection of the 14-3-3 protein in unselected patients with dementia. Neurology 2001; 56: 1528\u20131533.","journal-title":"Neurology"},{"key":"BF4001220_CR4","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/sj.mp.4000269","volume":"2","author":"K Iqbal","year":"1997","unstructured":"Iqbal K, Grundke-Iqbal I . Mechanism of Alzheimer neurofibrillary degeneration and the formation of tangles. Mol Psychiatry 1997; 2: 178\u2013180.","journal-title":"Mol Psychiatry"},{"key":"BF4001220_CR5","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0304-3940(97)00215-2","volume":"225","author":"M Otto","year":"1997","unstructured":"Otto M, Wiltfang J, Tumani H, Zerr I, Lantsch M, Kornhuber J et al. Elevated levels of Tau protein in CSF of patients with Creutzfeldt\u2013Jakob disease. Neurosci Lett 1997; 225: 210\u2013212.","journal-title":"Neurosci Lett"},{"key":"BF4001220_CR6","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1212\/WNL.52.8.1555","volume":"52","author":"F Hulstaert","year":"1999","unstructured":"Hulstaert F, Blennow K, Ivanoiu A, Schoonderwaldt HC, Riemenschneider M, De Deyn PP et al. Improved discrimination of Alzheimer's disease patients using beta-amyloid (1\u201342) and tau levels in CSF. Neurology 1999; 52: 1555\u20131562.","journal-title":"Neurology"},{"key":"BF4001220_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0304-3940(98)00904-5","volume":"259","author":"A Green","year":"1999","unstructured":"Green A, Harvey R, Thompson E, Rossor MN . Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease. Neurosci Lett 1999; 259: 133\u2013135.","journal-title":"Neurosci Lett"},{"key":"BF4001220_CR8","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Folstein M, Katzman R, Price D, Stadlan EM . Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939\u2013944.","journal-title":"Neurology"},{"key":"BF4001220_CR9","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","volume":"51","author":"D Neary","year":"1998","unstructured":"Neary D, Snowden J, Gustafson L, Passant U, Stuss D, Black S et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546\u20131554.","journal-title":"Neurology"},{"key":"BF4001220_CR10","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/ana.410430611","volume":"43","author":"R Will","year":"1998","unstructured":"Will R, Alperovitch A, Poser S, Pocchiari M, Hofman A, Mitrova E et al. Descriptive epidemiology of Creutzfeldt\u2013Jakob disease in six European countries, 1993\u20131995. EU collaborative study group for CJD. Ann Neurol 1998; 43: 763\u2013767.","journal-title":"Ann Neurol"},{"key":"BF4001220_CR11","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1212\/WNL.44.4.609","volume":"44","author":"KA Welsh","year":"1994","unstructured":"Welsh KA, Butters N, Mohs RC, Beekly D, Edland S, Fillenbaum G et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology 1994; 44: 609\u2013614.","journal-title":"Neurology"},{"key":"BF4001220_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0304-3940(00)01036-3","volume":"285","author":"E Vanmechelen","year":"2000","unstructured":"Vanmechelen E, Vanderstichele H, Davidsson P, Van Kerschaver E, Van Der Perre B, Sj\u00f6gren M et al. Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization. Neurosci Lett 2000; 285: 49\u201352.","journal-title":"Neurosci Lett"},{"key":"BF4001220_CR13","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1111\/j.1471-4159.1993.tb09823.x","volume":"61","author":"M Vandermeeren","year":"1993","unstructured":"Vandermeeren M, Mercken M, Vanmechelen E, Six J, Van de Voorde A, Martin JJ et al. Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay. J Neurochem 1993; 61: 1828\u20131834.","journal-title":"J Neurochem"},{"key":"BF4001220_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000008108","volume":"42","author":"M Herrmann","year":"1999","unstructured":"Herrmann M, Golombowski S, Kr\u00e4uchi K, Frey P, Mourton-Gilles C, Hulette C et al. ELISA-quantitation of phosphorylated tau protein in the Alzheimer's disease brain. Eur Neurol 1999; 42: 205\u2013210.","journal-title":"Eur Neurol"},{"key":"BF4001220_CR15","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/31508","volume":"393","author":"M Hutton","year":"1998","unstructured":"Hutton M, Lendon C, Rizzu P, Baker M, Froelich S, Houlden H et al. Association of missense and 5\u2032-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998; 393: 702\u2013705.","journal-title":"Nature"},{"key":"BF4001220_CR16","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S0140-6736(99)05207-1","volume":"355","author":"D Mann","year":"2000","unstructured":"Mann D, McDonagh A, Snowden J, Neary D, Pickering-Brown SM . Molecular classification of the dementias. Lancet 2000; 355: 626.","journal-title":"Lancet"},{"key":"BF4001220_CR17","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1136\/jnnp.70.5.624","volume":"70","author":"M Sj\u00f6gren","year":"2001","unstructured":"Sj\u00f6gren M, Davidsson P, Tullberg M, Minthon L, Wallin A, Wikkelso C et al. Both total and phosphorylated tau are increased in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2001; 70: 624\u2013630.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF4001220_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0304-3940(00)01697-9","volume":"297","author":"C Hesse","year":"2001","unstructured":"Hesse C, Rosengren L, Andreasen N, Davidsson P, Vanderstichele H, Vanmechelen E et al. Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke. Neurosci Lett 2001; 297: 187\u2013190.","journal-title":"Neurosci Lett"},{"key":"BF4001220_CR19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0304-3940(00)01178-2","volume":"287","author":"R Kohnken","year":"2000","unstructured":"Kohnken R, Buerger K, Zinkowski R, Miller C, Kerkman D, De Bernadis J et al. Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients. Neurosci Lett 2000; 287: 187\u2013190.","journal-title":"Neurosci Lett"},{"key":"BF4001220_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0304-3940(99)00476-0","volume":"270","author":"K Ishiguro","year":"1999","unstructured":"Ishiguro K, Ohno H, Arai H, Yamaguchi H, Urakami K, Park JM et al. Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease. Neurosci Lett 1999; 270: 91\u201394.","journal-title":"Neurosci Lett"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/4001220.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4001220","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4001220.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T03:31:25Z","timestamp":1648783885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/4001220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["BF4001220"],"URL":"https:\/\/doi.org\/10.1038\/sj.mp.4001220","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3]]},"assertion":[{"value":"1 March 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2002","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2002","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2003","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}